CorMedix (CRMD) Profit After Tax (2010 - 2026)

CorMedix has reported Profit After Tax for 16 years, with the latest figure at -$1.8 million in Q4 2025.

• Quarterly Profit After Tax fell 90039.64% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.8 million (up 89.43% YoY) and the FY2025 annual result came in at -$88000.0, down 2833.33% from the prior year.
• Profit After Tax eased to -$1.8 million in Q4 2025 per CRMD's latest filing, from $8205.0 in the prior quarter.
• Over five years, Profit After Tax peaked at $8205.0 in Q3 2025 and troughed at -$14.7 million in Q4 2023.
• A 5-year average of -$6.1 million and a median of -$7.1 million in 2021 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 100.3% in 2025, down 90039.64% in 2025.
• Over 5 years, Profit After Tax stood at -$7.8 million in 2021, then slipped by 5.34% to -$8.2 million in 2022, then sank by 79.63% to -$14.7 million in 2023, then jumped by 100.01% to $1988.0 in 2024, then tumbled by 90039.64% to -$1.8 million in 2025.
• According to Business Quant data, Profit After Tax over the past three periods registered -$1.8 million, $8205.0, and -$5121.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.